Open Access Open Access  Restricted Access Subscription Access

A review of dietary supplementation with L-arginine in the management of hypertension

Devshree Yashwantbhai Patel, Harsha Vasudev Chaudhari, Aniket Rajesing Girase, Dr. Javesh Kashinath Patil

Abstract


An amino acid is the basic chemical that serves as a protein building block. A protein is made up of one or more chains of amino acids (called polypeptides) that are encoded in a gene. Some amino acids are synthesised in the body,they arealanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, and tyrosine.. L-arginine is one of several amino acids required by the body to function effectively. L-arginine, like other amino acids, helps for protein synthesis. Protein is used by the body to help build muscle and repair tissue. It transforms this amino acid into the molecule nitric oxide, which aids in the opening of blood vessels. L-arginine has been studied for its effectiveness in treating high blood pressure and chest pain. Endothelial dysfunction and reduced nitric oxide (NO) bioactivity represent prominent pathophysiological abnormalities associated with hypertensive cardiovascular disease. As we know Hypertension, often known as high or an increase of blood pressure, is a condition characterised by chronically elevated blood vessel pressure. Hypertension is a chronic condition that affects over 972 million people worldwide and 188.3 million people in India. High blood pressure is estimated to cause 7.5 million death worldwide, accounting for around 12.8% of all deaths. In this papers we are focusing on dietary supplements of L -arginine in the treatment of hypertension.


Full Text:

PDF

References


Global burden of hypertension: analysis of worldwide data. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Lancet. 2005;365:217–223.

James, William Philip T. “The epidemiology of obesity: the size of the problem.” Journal of internal medicine 263.4 (2008): 336-352.

SS Lim, T Vos, AD Flaxman, G Danaei, K Shibuya, H Adair-Rohani, MA AlMazroa, M Amann, HR Anderson, KG Andrews A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Abukhodair A W, Abukhudair W, Alqarni M S (December 17, 2021) The Effects of L-Arginine in Hypertensive Patients: A Literature Review. Cureus 13(12): e20485. Doi:10.7759/cureus.20485

https://www.augustahealth.com/answer/l-arginine-does-it-lower-blood-pressure/

https://origympersonaltrainercourses.co.uk/files/img_cache/10604/1920_1611329377_howtotakel-arginine.png?1611330247

Quyyumi AA, Cannon RO, 3rd, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992; 86: 1864-71.

Treasure CB, Klein JL, Vita JA, et al. Hypertension and left Ventricular hypertrophy are associated with impaired endothelium-Mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.

Egashira K, Suzuki S, Hirooka Y, et al. Impaired endothelium-Dependent vasodilation of large epicardial and resistance coronary Arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 1995; 25: 201-6

Marzilli M, Taddei S, Virdis A, Ghiadoni L, Salvetti A. Endothelial Function and coronary microcirculaiton in essential hypertension. J Hypertension 1998; 16 (suppl 8): S59-S63


Refbacks

  • There are currently no refbacks.